{"id":55434,"date":"2023-04-03T05:03:09","date_gmt":"2023-04-03T03:03:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/"},"modified":"2023-04-03T05:03:09","modified_gmt":"2023-04-03T03:03:09","slug":"dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/","title":{"rendered":"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products"},"content":{"rendered":"
\n

\n– New joint venture will conduct production control –<\/b><\/p>\n

TOKYO–(BUSINESS WIRE)–Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) and SCIVAX Co., Ltd. have entered into a capital and operational alliance regarding a foundry business designed to mass-produce nanoimprinted products. A production control joint venture, Nanoimprint Solutions Co., Ltd., (Nanosol) was established on April 3, 2023.
\n
Our two companies will combine our strengths for the mass production of nanoimprinted products.<\/p>\n

<\/a>
<\/a><\/p>\n

\n[Background]<\/b><\/p>\n

\nNanoimprinting is expected to be used in a wide range of fields. These include 3D sensor devices, smart glasses, along with next-generation DNA sequencer bio-device elements.<\/p>\n

\nIn anticipation of future market expansion, we have entered into an operational alliance to ensure the stable supply of mass-produced nanoimprinted products.<\/p>\n

\n[New Alliance]
\n
<\/b>We will combine DNP strengths in cutting-edge nanoimprint master mold manufacturing technology, mass production and quality control know-how, with SCIVAX strengths in mass-production manufacturing equipment capable of high-precision nanoimprinting, equipment design technology, and process know-how to further integrate the value chains of both of our companies.<\/p>\n

\nAs a result, we will develop a system in Japan that can rapidly respond to the mass production outsourcing needs, which will also lead to capabilities in responding to global supply chain risks.
\n
We will choose to manufacture products at the best suited manufacturing plants of two companies, under production control conducted by Nanosol.<\/p>\n

\n[New Company Summary]<\/b><\/p>\n\n\n\n\n\n\n
\n

\nCompany name<\/p>\n<\/td>\n

\n

\nNanoimprint Solutions Co., Ltd.<\/p>\n<\/td>\n<\/tr>\n

\n

\nLocation<\/p>\n<\/td>\n

\n

\n1-1-1 Ichigaya Kaga-cho, Shinjuku-ku, Tokyo<\/p>\n<\/td>\n<\/tr>\n

\n

\nCapital<\/p>\n<\/td>\n

\n

\n10 million yen<\/p>\n<\/td>\n<\/tr>\n

\n

\nBusiness contents<\/p>\n<\/td>\n

\n

\nMass production management of nanoimprint contract business<\/p>\n<\/td>\n<\/tr>\n

\n

\nOwnership stake<\/p>\n<\/td>\n

\n

\nDNP 50%\u3001SCIVAX 50%<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n[Future Prospects]
\n
<\/b>Through the newly established Nanosol, we will respond to the needs for mass production of nanoimprinted products for various applications. We aim for annual sales of approximately 10 billion yen by 2026.<\/p>\n

\nMore details<\/a><\/p>\n

\nAbout DNP<\/a><\/b><\/p>\n

\nDNP was established in 1876, and has become a leading global company that leverages print-based solutions to engineer fresh business opportunities while protecting the environment and creating a more vibrant world for all. We capitalize on core competencies in microfabrication and precision coating technology to provide products for the display, electronic device, and optical film markets. We have also developed new products, such as vapor chamber and reflect array that offer next-generation communication solutions for more people-friendly information society.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia contact<\/b>
DNP:
\n
Yusuke Kitagawa, 81-3-6735-0101
\n
kitagawa-y3@mail.dnp.co.jp<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

– New joint venture will conduct production control – TOKYO–(BUSINESS WIRE)–Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) and SCIVAX Co., Ltd. have entered into a capital and operational alliance regarding a foundry business designed to mass-produce nanoimprinted products. A production control joint venture, Nanoimprint Solutions Co., Ltd., (Nanosol) was established on April 3, 2023. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55434","6":"format-standard","7":"category-industry"},"yoast_head":"\nDai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"– New joint venture will conduct production control – TOKYO–(BUSINESS WIRE)–Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) and SCIVAX Co., Ltd. have entered into a capital and operational alliance regarding a foundry business designed to mass-produce nanoimprinted products. A production control joint venture, Nanoimprint Solutions Co., Ltd., (Nanosol) was established on April 3, 2023. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-03T03:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230330005411\/en\/1753947\/21\/Nanoimprintsolutions.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products\",\"datePublished\":\"2023-04-03T03:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/\"},\"wordCount\":398,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005411\\\/en\\\/1753947\\\/21\\\/Nanoimprintsolutions.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/\",\"name\":\"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005411\\\/en\\\/1753947\\\/21\\\/Nanoimprintsolutions.jpg\",\"datePublished\":\"2023-04-03T03:03:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005411\\\/en\\\/1753947\\\/21\\\/Nanoimprintsolutions.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005411\\\/en\\\/1753947\\\/21\\\/Nanoimprintsolutions.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/","og_locale":"en_US","og_type":"article","og_title":"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products - Pharma Trend","og_description":"– New joint venture will conduct production control – TOKYO–(BUSINESS WIRE)–Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) and SCIVAX Co., Ltd. have entered into a capital and operational alliance regarding a foundry business designed to mass-produce nanoimprinted products. A production control joint venture, Nanoimprint Solutions Co., Ltd., (Nanosol) was established on April 3, 2023. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-03T03:03:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230330005411\/en\/1753947\/21\/Nanoimprintsolutions.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products","datePublished":"2023-04-03T03:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/"},"wordCount":398,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005411\/en\/1753947\/21\/Nanoimprintsolutions.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/","url":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/","name":"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005411\/en\/1753947\/21\/Nanoimprintsolutions.jpg","datePublished":"2023-04-03T03:03:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230330005411\/en\/1753947\/21\/Nanoimprintsolutions.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230330005411\/en\/1753947\/21\/Nanoimprintsolutions.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dai-nippon-printing-and-scivax-enter-into-capital-and-operational-alliance-in-foundry-business-for-mass-production-of-nanoimprinted-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55434"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55434\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}